Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Meiser

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 31, 1999
Coronary risk factor management for the prevention and treatment of graft vessel disease in heart transplant patientsB R Jaeger, J Schirmer, J Thiery, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 13, 2001
Suggested guidelines for the use of tacrolimus in cardiac transplant recipientsD O Taylor, M L Barr, B M Meiser, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 1, 1993
The influence of gastrointestinal agents on resorption and metabolism of cyclosporine after heart transplantation: experimental and clinical resultsH Reichenspurner, B M Meiser, F Muschiol, et al.
Transplantation Proceedings|March 27, 2001
Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?J Groetzner, B M Meiser, J Schirmer, et al.
Transplantation Proceedings|October 1, 1992
A new chimeric monoclonal CD4 antibody for prevention of rejection after heart transplantationB M Meiser, C Reiter, M Ebel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 1, 1994
How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?F M Wagner, H Reichenspurner, P Uberfuhr, et al.
Transplantation Proceedings|February 1, 1993
Selection and chimerization of a monoclonal CD4 antibody for heart transplantationC Reiter, B M Meiser, P Uberfuhr, et al.
Transplantation Proceedings|October 1, 1994
Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agentsH Reichenspurner, B M Meiser, F Muschiol, et al.
Herz|January 24, 1998
[Heart transplantation--state of the art today]B M Meiser, W von Scheidt, M Weis, et al.
Transplantation Proceedings|October 1, 1992
Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft modelB M Meiser, S Wolf, C Devens, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 31, 1999
Coronary risk factor management for the prevention and treatment of graft vessel disease in heart transplant patientsB R Jaeger, J Schirmer, J Thiery, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 13, 2001
Suggested guidelines for the use of tacrolimus in cardiac transplant recipientsD O Taylor, M L Barr, B M Meiser, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 1, 1993
The influence of gastrointestinal agents on resorption and metabolism of cyclosporine after heart transplantation: experimental and clinical resultsH Reichenspurner, B M Meiser, F Muschiol, et al.
Transplantation Proceedings|March 27, 2001
Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?J Groetzner, B M Meiser, J Schirmer, et al.
Transplantation Proceedings|October 1, 1992
A new chimeric monoclonal CD4 antibody for prevention of rejection after heart transplantationB M Meiser, C Reiter, M Ebel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 1, 1994
How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?F M Wagner, H Reichenspurner, P Uberfuhr, et al.
Transplantation Proceedings|February 1, 1993
Selection and chimerization of a monoclonal CD4 antibody for heart transplantationC Reiter, B M Meiser, P Uberfuhr, et al.
Transplantation Proceedings|October 1, 1994
Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agentsH Reichenspurner, B M Meiser, F Muschiol, et al.
Herz|January 24, 1998
[Heart transplantation--state of the art today]B M Meiser, W von Scheidt, M Weis, et al.
Transplantation Proceedings|October 1, 1992
Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft modelB M Meiser, S Wolf, C Devens, et al.
Pageof 5